News

Zacks Investment Research on MSN2d
BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
BioMarin Pharmaceutical BMRN reported second-quarter 2025 adjusted earnings per share (EPS) of $1.44, which beat the Zacks ...
U.S. News & World Report2d
iShares Morningstar Small-Cap Growth ETF (ISCG) - U.S. News
Learn everything you need to know about iShares Morningstar Small-Cap Growth ETF (ISCG) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to ...
U.S. News & World Report2d
iShares Morningstar Mid-Cap Growth ETF (IMCG) - U.S. News
Learn everything you need to know about iShares Morningstar Mid-Cap Growth ETF (IMCG) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see ...
Ophthalmology Advisor3d
In Geographic Atrophy, 4-Year Data Supports Early Pegcetacoplan Treatment
Researchers reported efficacy and safety data through 48 months of continuous pegcetacoplan treatment across OAKS, DERBY and ...